EGFR and cancer: KEGG signaling pathway enrichment analysis showed that both groups had EGFR tyrosine kinase inhibitor resistance and gene mutations associated with cancer transcription disorders, but the non‐cancer group also focused on viral infection‐related pathways, and the cancer group had greater enrichment of microRNA‐related pathways and epigenetic‐related gene mutations (Figure S2A–E).